Browsing by Subject "A61P 9/10"

Now showing items 1-6 of 6

    • Beta-lactone compounds 
      Smith, Jeffrey W.; Romo, Daniel; Ma, Gil; Zancanella, Manuel (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-09-04)
      The present invention provides compounds having the general structure A, or a pharmaceutically acceptable derivatives thereof: wherein R is an alkyl group, and R1 comprises at least one moiety selected from a group ...
    • Bioactive complexes compositions and methods of use thereof 
      Gurin, Michael H. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2010-08-24)
      A bioactive complex composition having enhanced oxidative stability, emulsion stability, mineral rich transparent beverages and a wide range of functional health benefits. The composition may include as a base composition ...
    • Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage 
      Prockop, Darwin J.; Lee, Ryanghwa (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-07-31)
      The present invention provides compositions comprising mesenchymal stem cells (MSCs), and methods for their novel use in the repair of cardiac damage and treatment of inflammatory diseases. The invention also provides ...
    • Method and compositions for inhibiting thrombin-induced coagulation 
      Davis, Stacey; Hook, Magnus A. O. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2004-12-28)
      A method of achieving safe and effective treatment or prevention of potentially harmful blood clots, or in inhibiting the coagulation of blood when so desired such as during a wide array of disease conditions including ...
    • Method of treating endothelial dysfunction comprising administration of a thrombin peptide derivative 
      Carney, Darrell H.; Olszewska-pazdrak, Barbara; Fossum, Theresa W. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-12-18)
      Endothelial dysfunction (ED) is associated with a number of diseases and disorders. Agonists of the non-proteolytically activated thrombin receptor can be used in methods to treat ED or ED-related diseases and disorders.
    • Treatment of stroke using domain V of perlecan 
      Bix, Gregory J. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2013-06-18)
      The present invention is drawn to methods of stimulating or enhancing angiogenesis in a patient comprising, administering to said patient a therapeutically effective amount of an endorepellin protein, wherein said endorepellin ...